This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Oncolytic Viruses / Non-viral Gene Therapy Delivery
November 30 - December 1, 2022
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET
Menu

Steve Thorne
CSO at KaliVir Immnuotherapeutics, USA
Speaker

Agenda Sessions

  • A Novel Oncolytic Virotherapy, VET3-TGI, Displays Potent Therapeutic Activity in Multiple Mouse Tumor Models through Blocking TGF-beta and Augmenting Type-1 Immune Response

    , 9:50am
    View Session

At this event

Prev
Next
Akshata Udyavar
Sr. Director Immunology and Translational Sciences
Actym Therapeutics, Inc., USA

See Steve at Oncolytic Viruses / Non-viral Gene Therapy Delivery